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Abstract
Previous experimental evidence indicates that some cancer cells have an alternative glycolysis pathway with net zero ATP
production, implying that upregulation of glycolysis in these cells may not be related to the generation of ATP. Here we use
a genome-scale model of human cell metabolism to investigate the potential metabolic alterations in cells using net zero
ATP glycolysis. We uncover a novel pathway for ATP generation that involves reactions from serine biosynthesis, one-carbon
metabolism and the glycine cleavage system, and show that the pathway is transcriptionally upregulated in an inducible
murine model of Myc-driven liver tumorigenesis. This pathway has a predicted two-fold higher flux rate in cells using net
zero ATP glycolysis than those using standard glycolysis and generates twice as much ATP with significantly lower rate of
lactate - but higher rate of alanine secretion. Thus, in cells using the standard - or the net zero ATP glycolysis pathways a
significant portion of the glycolysis flux is always associated with ATP generation, and the ratio between the flux rates of the
two pathways determines the rate of ATP generation and lactate and alanine secretion during glycolysis.
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Introduction
Oxidative phosphorylation (OxPhos) in the mitochondria is the
major pathway for ATP generation in normal cells under normal
oxygen conditions (normoxia), generating 32 mole of ATP per
mole of glucose [1]. In contrast, under conditions of oxygen
limitation (hypoxia), the mitochondrial activity is down-regulated
and cells switch to glycolysis for ATP generation that yields only 2
mole of ATP per mole of glucose. Surprisingly, as first observed by
Warburg [2], the metabolism of cancer cells is frequently
characterized by a significant upregulation of glycolysis even
under normoxic conditions, with both an increased glucose uptake
and excretion of lactate (Warburg effect, aerobic glycolysis). More
recently, it became evident that the Warburg effect is not unique
to cancer cells alone. Indeed, both rapidly proliferating normal
cells [3,4,5,6,7,8] and non-proliferating cells with high metabolic
activity [9,10,11] display high levels of glycolysis with lactate
excretion under normoxic conditions.
Despite the importance of OxPhos and aerobic glycolysis in
ATP generation, previous empirical evidence indicates that some
cancer cells also utilize an alternative glycolysis pathway with net
zero ATP generation [12,13]. This striking observation implies a
physiological role for aerobic glycolysis other than ATP genera-
tion. One such role may be the capacity of glycolysis to fulfill the
need of rapidly proliferating cells for precursor metabolites.
However, it has been shown previously that the need for precursor
metabolites in itself is not sufficient to explain the high glycolysis
rates observed in proliferating cells [14,15]. Instead, molecular
crowding and its resulting constraint on macromolecular concen-
trations is the key factor determining the Warburg effect [15,16].
The high density of macromolecules in the cell imposes limits on
the total mitochondrial content per unit of cell volume and the
total content of ribosomes and metabolic enzymes as well. In turn,
the inherent limitation in mitochondrial density results in an upper
bound on the maximum achievable OxPhos capacity. We have
shown previously that this maximum is achieved at physiological
conditions and that it results in a metabolic switch involving an
upregulation of glycolysis and lactate excretion [15,16]. Yet, all
these results were obtained making use of the standard glycolysis
pathway, with a yield of 2 moles of ATP per mole of glucose.
Here we investigate the metabolic flux redistributions in
proliferating cells that utilize the alternative glycolysis pathway
with net zero ATP production [12,13]. To this end we improve on
our previous flux balance model of human cell metabolism [15] by
more precisely accounting for protein synthesis, including a self-
consistent constraint that all ribosomal-, enzyme associated-, and
non-metabolic proteins need to be accounted for by the rate of
protein synthesis, which is proportional to the ribosomal density.
We also make a more precise accounting of the molecular crowding
constraint by considering mitochondria as a subcellular compart-
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ment independent from the cytosol. Using this model we uncover a
novel pathway for ATP generation that involves reactions in the
serine biosynthesis, one-carbon metabolism and the glycine
cleavage system, and show that the pathway is transcriptionally
upregulated in an inducible murine model of Myc-driven liver
tumori-genesis. The flux rate of this pathway is predicted to be two-
fold higher in cells with net zero ATP glycolysis relative to cells with
the standard glycolysis. Furthermore, it accounts for most of the
glycolysis rate in cells with net zero ATP glycolysis.
Results
Flux balance model of cell metabolism with molecular
crowding constraint
As starting point, we utilize a genome-scale metabolic
reconstruction of a generic human cell [17] that includes most
biochemical reactions catalyzed by enzymes encoded in the
human genome. We add auxiliary reactions to represent nutrient
uptake, excretion of metabolic byproducts, basal ATP demand
needed for cell maintenance, basal rate of protein degradation,
synthesis of cell biomass components (proteins, lipids, RNA and
DNA) and cell proliferation (biomass components R cell) (Table
S1). We assume that the cell is in a steady state where the
production and consumption of every metabolite and macromol-
ecules balances, known as the flux balance constraint [17]. We use
Smi to denote the stoichiometric coefficient of metabolite m in
reaction i. We use fi to denote the steady state reaction rate (flux) of
the ith reaction in the metabolic network, where all reversible
reactions are represented by a forward and backward rate,
respectively. Reactions are divided into nutrient import reactions
(RI), reactions taking place outside the mitochondria (RnM) and
reactions taking place in the mitochondria (RM). We use wc to
denote the relative cell volume fraction occupied by the cth cellular
compartment, where a compartment represents the overall
contribution of macromolecules of certain type (e.g., ribosomes)
or of certain cell organelle (e.g., mitochondria). Specifically, here
we consider proteins that do not form part of enzyme complexes
or ribosomes (P0), all metabolic enzymes catalyzing reactions
outside the mitochondria (EnM), all metabolic enzymes catalyzing
reactions in the mitochondria (EM), ribosomes (R), and mitochon-
dria (M). We assume the proliferation rate (m) and the total relative
volume fraction occupied by macromolecules and organelles (wmax)
are known and are given as input parameters of the model. Finally,
we estimate the metabolic fluxes and compartment densities as the
solution of the following optimization problem:
Find the fi and wc that minimize the sum of nutrient import costs
X
i[RI
cifi ð1Þ
subject to the metabolic constraints: flux balance constraints
X
i
Smifi~0 ð2Þ
minimum/maximum flux constraints
ni,minƒfiƒni,max ð3Þ
minimum/maximum volume fraction constraints
0ƒwcƒwmax ð4Þ
molecular crowding constraints
P
i[RnM
aifiƒwEnM
P
i[RM
aifiƒwM
aM,ATPfATP synthaseƒwM
aRfprotein synthesisƒwR
wP0zwEnMzwRzwMƒwmax
ð5Þ
where ci is the nutrient import cost associated with the uptake
reaction i, ai= vi/keff,i are the crowding coefficients of metabolic
enzymes (enzyme molar volume/enzyme effective turnover) [18],
aR= vR/kR is the ribosome crowding coefficient (ribosome molar
volume/protein synthesis rate per ribosome), and aM,ATP= vs,M/rM
the crowding coefficient of mitochondria ATP generation (ATP
synthesis rate per mitochondria mass/mitochondria specific
volume) [15,16].
The estimation of all the model parameters is presented in the
Methods section. Here we discuss some of them that deserve
particular attention. The cost of importing molecules is in general
determined by their size, charge and hydrophilic properties. In a
first approximation we assume that the cost of importing molecules
is proportional to their size and use the molecular weight as a
surrogate for size. Within this approximation the import cost ci is
equal to the molecular weight of the molecule imported in the
auxiliary uptake reaction i (Table S1). The effective turnover
numbers keff,i, quantify the reaction rate per enzyme molecule. For
example, for an irreversible single substrate reaction satisfying
Michaelis-Menten kinetics, keff= kS/(K+S), where k is the enzyme
turnover number, K the half-saturation concentration and S the
substrate concentration. The turnover numbers of some human
enzymes are reported in the BRENDA database [19]. They have a
typical value of 10 sec21 and a significant variation from 1 to
100 sec21 (Table S2). However, for most reactions we do not
know the turnover number, the kinetic model, or the metabolite
concentrations, impeding us to estimate keff. To cope with this
indeterminacy we performed a sampling strategy, whereby the keff,i
were sampled from a reasonable range of values, and then focused
on the predicted average behavior and 90% confidence intervals
(see Methods for additional details). The typical enzyme crowding
coefficient is about ai,0.00013 (mM/min)21, which is interpreted
as follows: to maintain a reaction rate of 1 mM/min we need to
allocate a relative cell volume of 0.00013 (0.013%) for the
corresponding enzyme. The crowding coefficients are significantly
larger for ribosomes and the mitochondria: aR=3.6 (mM/min)
21
and aM,ATP=0.017 (mM/min)
21, respectively.
The flux balance equation for proteins (equation (2) with
m= proteins) is formulated more generally than before. Previous
models have assumed a constant protein concentration and have
not taken into account the self-consistent need to synthesize all the
proteins in enzyme complexes and ribosomes [14,15]. In contrast,
here we account for three major categories, proteins not associated
with metabolism, proteins that are components of enzyme
complexes, and ribosomal proteins, with their concentrations
(moles/cell volume) denoted by P0, PE, and PR, respectively. In
proliferating cells, these concentrations will decrease at a rate
(m+kD)(P0+PE+PR), where m denotes the proliferation rate and kD
the basal rate of protein turnover. The total concentration of
proteins in enzyme complexes can be estimated as PE= nPEE=
nPESifi/keff,i, where nPE is the average number of proteins in an
enzyme complex (about 2.4) and E is the total concentration of
metabolic enzymes. Similarly, PR= nPRwR/vR, where nPR is the
number of proteins in a ribosome (82 for the 80S ribosomes) and
Novel Pathway for ATP Generation
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wR/vR is the concentration of ribosomes. Putting all these elements
together, the balance between protein turnover and synthesis
implies fProtein_sysnthesis= (m+kD)[P0+nPESi(fi/keff,i)+(nPR/vR)wR], where
the term (m+kD)P0 is the only one considered in previous models
[14,15,17]. In an effective manner, each metabolic reaction
contributes to a component of protein synthesis, with a
stoichiometric coefficient (m+kD)nPE/keff,i, quantifying the amount
of protein necessary to keep the concentration of the correspond-
ing enzyme constant. Similarly, a constant ribosome volume
fraction also accounts for a component of protein synthesis, with a
stoichiometric coefficient (m+kD)nPR/vR, quantifying the amount of
protein necessary to keep the ribosomes concentration constant.
The rate of protein synthesis accounting for this effective protein
dilution/degradation thus models the autocatalytic nature of cell
metabolism, whereby the macromolecular complexes catalyzing
the metabolic reactions ultimately are themselves a product of
metabolism.
To model the alternative glycolysis pathway we replaced the
pyruvate kinase catalyzed reaction: Phosphoenolpyruvate+ADP+
H+RPyruvate+ATP, by the ATP independent reaction: Phosphoe-
nolpyruvate+H+RPyruvate+Phosphate. In the latter reaction phos-
phoglycerate mutase (PGM1) is a candidate phosphate acceptor,
which is then dephosphorylated by a yet unknown mechanism [12].
Changes in the relative macromolecular densities with
increased cell proliferation
Figure 1 shows the predicted relative volume fraction occupied
by non-mitochondrial enzymes (wEnM=Si|EnMaifi), mitochondria
(wM), and ribosomes (wR) as a function of the proliferation rate for
cells growing in a medium containing glucose, glutamine, essential
amino acids, and oxygen. The ribosomal density increases
monotonically with increasing the proliferation rate in a nonlinear
fashion, reaching a maximum of 10% of the cell volume at the
highest proliferation rate of approximately 2.79/day (minimum
doubling time of ln(2)/mmax=6 hours) (Fig. 1, blue circles). At low
proliferation rates the mitochondrial density increases with
increasing the proliferation rate from 10% to about 30% of the
cell volume (Fig. 1, green triangles). However, beyond a
proliferation rate of about 0.8/day (doubling time 21 hours), the
mitochondrial density decreases with increasing the proliferation
rate. This is in turn accompanied by a dramatic increase in the
density of metabolic enzymes (Fig. 1, red squares). Our model thus
predicts that when switching from low to high proliferation rates,
the cell makes a transition from a mitochondria dominated
molecular crowding regime to one dominated by enzymes +
ribosomes (Fig. 1).
The impact of altering the different model parameters on the
behavior of the model can also be tested. Larger values of the
mitochondrial crowding coefficient aM, e.g., due to a decrease in
mitochondrial efficiency for ATP generation, will cause a decrease
of mitochondrial density at lower proliferation rates. Larger
ribosome crowding coefficient aR, e.g., due to a decrease in protein
synthesis efficiency, will result in a faster increase of the ribosome
density with increasing the proliferation rate, and a consequently
faster decrease of the mitochondria density. Similarly, an increase
in the average crowding coefficient of metabolic enzymes will
cause a faster increase of the total enzyme concentration with
increasing the proliferation, resulting in a faster decrease of the
mitochondrial density as well. Cancer cells are characterized by
partial alterations in all of these components, potentially resulting
in a more dramatic effect than that depicted in Figure 1. In
particular, mutations leading to damaged mitochondria will
enhance the effect, as originally hypothesized by Warburg [2].
Metabolic switch from low- to high proliferation rates
The predicted transition in the macromolecular composition of
the cell is accompanied by a global switch in the cell’s metabolic
state (Fig. 2). At the proliferation rate of about 0.8/day (doubling
Figure 1. Cell component densities at different proliferation rates. Model predicted relative cell volume fraction occupied by metabolic
enzymes (red squares), ribosomes (blue circles) and mitochondria (green triangles), respectively. The model-predicted median and 90% confidence
intervals are shown.
doi:10.1371/journal.pone.0025881.g001
Novel Pathway for ATP Generation
PLoS ONE | www.plosone.org 3 November 2011 | Volume 6 | Issue 11 | e25881
time 21 hours) the model predicts a substantial increase in glucose
uptake, sudden activation of glutamine uptake and a-ketoglutarate
dehydrogenase activity, complete deactivation of pyruvate decar-
boxylase (PCm) and activation of pyruvate dehydrogenase
(PDHm). The activity of pyruvate carboxylase in the low
proliferation regime, where there is no glutamine uptake, is
consistent with recent experimental data showing that pyruvate
carboxylase is needed for growth without glutamine [20]. The
activation of glutamine uptake at high proliferation rates is also in
agreement with what have been observed experimentally [21]. We
also observe activation of lactate excretion at high proliferation
rates, the hallmark of the Warburg effect.
Several notable changes take place around the pyruvate
branching point (Fig. 2). Most noticeably, the glycolysis pathway
(Fig. 2) is truncated at 3-phosphoglycerate and the flux over the
ATP-decoupled pyruvate kinase-catalyzed reaction is zero at all
proliferation rates. We emphasize that we have not imposed a zero
flux over this reaction, and the zero flux is a prediction of the
model itself. Phenylalanine, isoleucine, lysine and valine are the
major sources of TCA cycle intermediates and pyruvate (via
malate) at low proliferation rates. However, at high proliferation
rates the TCA cycle intermediates and pyruvate are instead
generated from glutamine. The cytosolic- (LDH-L) and mito-
chondrial L-lactate dehydrogenases (LDH-Lm) form a cycle
between pyruvate and lactate. At low proliferation rates, LDH-L
converts pyruvate to lactate and LDH-Lm converts lactate back to
pyruvate, both reactions working at the same rate (Fig. 2,
pyruvate-lactate loop, dashed lines). At high proliferation rates
the cycle is reverted, LDH-L converting lactate to pyruvate and
LDH-Lm pyruvate back to lactate (Fig. 2, pyruvate-lactate loop,
solid lines). In the latter case the LDH-Lm catalyzed reaction has a
higher rate, resulting in the net production of lactate, which is then
excreted. Finally, at high proliferation alanine is produced from
pyruvate and is then excreted. We note the amino acid selectivity
for pyruvate and TCA cycle intermediates at low proliferation
rates depends on the specific choice of nutrient import cost in
equation (1). For example, assuming that the cost of nutrient
uptake is equal for all nutrients, we obtain that tryptophan is
utilized as a source of pyruvate at low proliferation rates (data not
shown). However, the high fluxes of glutamine uptake, the 3-
phosphoglycerate shift towards serine biosynthesis, and alanine
excretion at high proliferation rates, and the results described
below are independent of the choice of nutrient cost coefficients.
Novel pathway for ATP generation
When considering the molecular crowding constraint, our
simulations show that at high proliferation rates most of the
glycolysis rate is diverted towards the biosynthesis of serine (Fig. 2).
However, this flux rate exceeds by more than 10 fold the serine
requirements for protein synthesis (Fig. 2, serine to protein
synthesis, top center panel). Therefore, we hypothesized that cells
utilizing the net zero ATP glycolysis may overexpress some
alternative pathway for ATP generation.
To test this hypothesis we inspected the genome-scale reaction
rate predictions, focusing on reactions producing ATP. Following
this approach we identified the reactions with high rates of ATP
production in cells with a net zero ATP glycolysis at different
proliferation rates. At low proliferation rates (0.03/day, doubling
time 24 days) ATP synthase was the dominant reaction, supplying
most of the ATP required for cell maintenance (Fig. 3a,b, left
panels). On the other hand, at high proliferations rates (2.79/day,
doubling time 6 hours) the formate-tetrahydrofolate ligase
(FTHFL), working in the reverse direction to form ATP, is the
dominant reaction (Fig. 3a, right panel). Formate-tetrahydrofolate
ligase is also active in cells with the standard glycolysis (Fig. 3b,
right panel). However, in the case of standard glycolysis
phosphoglycerate kinase and pyruvate kinase are the dominant
reactions at high proliferation rates (Fig. 3b, right panel). Finally,
we note that the molecular crowding constraint is determinant in
the differential utilization of ATP synthase and FTHFL at high
proliferation rates. After removing this constraint from the model
(which mathematically is equivalent to set wmax=‘ in equation (5)),
we obtain a dramatic increase in the ATP synthase rate and a
decrease of the FTHFL rate at high proliferation rates (Fig. S1,
HIGH), compared to the predictions with the molecular crowding
constraint (Fig. 1a, HIGH).
By tracking back the flux from the formate-tetrahydrofolate
ligase-catalyzed reaction to glycolysis we uncovered a novel
pathway for ATP generation (Fig. 4). The pathway is composed
of three main steps. First, synthesis of L-serine from the glycolysis
intermediate metabolite 3-phosphoglycerate, using NAD and L-
glutamate as cofactors (Fig. 4a), with the overall reaction
3-phosphoglyceratezL-glutamatezNADzzH2O?
L-Serineza-KetoglutaratezHzzNADHzPhosphate
ð6Þ
Second, the conversion of L-serine to glycine with a concomitant one-
carbon metabolism cycle, resulting in the net generation of 1 mole
of ATP per mole of serine transformed, using NADP+ as a cofactor
(Fig. 4b), with the overall reaction
L-SerinezNADPzzH2OzADPzPhosphate?
GlycinezNADPHz2 HzzATP
ð7Þ
Finally, the conversion glycine to ammonium (NH4) in the mitochon-
dria with a concomitant one-carbon metabolism cycle, using
NAD+ and NADP+ as cofactors (Fig. 4c or d), with the overall
reaction
GlycinezNADPzzNADzzH2OzADPzPhosphate?
NH4zCO2zNADPHzNADHz2 H
zzATP
ð8Þ
This pathway has a net yield of 2 mole of ATP per mole of 3-
phosphoglycerate, therefore 4 mole of ATP per mole of glucose.
Furthermore, when compared to the standard glycolysis, the net
zero ATP glycolysis manifests a significant decrease in lactate
excretion while increasing the alanine excretion (Fig. 3a,b, right
panel).
Although the reactions in the reaction cycle shown in Figure 4b
are all annotated as reversible in the human metabolic network
reconstruction [22], the cycle may not work in the direction of
ATP production due to thermodynamic constraints. FTHFL can
efficiently catalyze the synthesis of ATP in the bacterium
Clostridium cylindrosporum [23]. However, it remains to be
elucidated whether this is also feasible in human cells, where
the tri-functional enzyme C1-tetrahydrofolate synthase is respon-
sible for the methylene-tetrahydrofolate dehydrogenase, methe-
nyl-tetrahydrofolate cyclohydrolase and FTHFL activities. To
address this issue, we have analyzed a kinetic model of the
reaction cycle shown in Figure 4b, focusing on the cytosolic
enzymes alone. The model is fully described in the Information
S1 and is based on a previous model of folate metabolism [24].
We demonstrate that the kinetic model has a stable steady state in
the direction of ATP production, indicating that the novel
pathway is thermodynamically feasible.
Novel Pathway for ATP Generation
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Figure 2. Metabolic switch with increasing proliferation rate. Schematic representation of the flux of selected metabolic reactions and
pathways at different proliferation rates, in cells utilizing glycolysis with net zero ATP production. The individual panels show the rate of the indicated
reactions (vertical axis, in units of mM/min=mmol/min/L) as a function of the proliferation rate (horizontal axis, in units of 1/day). The gray shadow
background contains reactions taking place in the mitochondria. Note, that the predicted metabolic switch is lost if the molecular crowding
constraint is removed from the model (see Fig S1). Abbreviations: metabolite import/export (Ex metabolite: glc = glucose, gln =glutamine, Ala-L = L-
alanine, phe-L = L-phenylalanine, ile-L = isoleucine, lys-L = L-lysine, val-L = L-valine, lac-L = L-lactate), phosphoglycerate kinase (PGK), pyruvate kinase
(PK), phosphoglycerate dehydrogenase (PGCD), L-alanine transaminase (ALATA-L), malic enzyme (ME), malate dehydrogenase (MDH), pyruvate
carboxylase (PC), pyruvate dehydrogenase (PDH), citrate synthase (CS), a-ketoglutarate dehydrogenase (AKGD).
doi:10.1371/journal.pone.0025881.g002
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The novel ATP-producing pathway is regulated by Myc
Consistent with our modeling results, the upregulation of serine
and glycine biosynthesis have been observed in some tumor types
before [25,26,27,28,29]. To start to gain insight into this pathway’s
regulation, we next aimed to identify transcription factors
regulating the novel ATP-producing pathway. We performed a
search of several transcription factor signatures annotated in the
Molecular Signatures Database (MSigDB) [30]. We identified Myc
as a transcriptional regulator of six out of the 11 genes in the
pathway: PHGDH, PSPH, SHMT1, MTHFD1, MTHFD2 and
GCSH (Myc Target Gene Database, [31]), indicating that Myc-
induced tumorigenesis may be intimately linked to the activation
of this pathway. To test this hypothesis, we have analyzed data
from a doxycycline-inducible murine model of Myc-driven liver
cancer [32], reporting gene expression microarrays at different
tumor stages. We find that the genes coding for the enzymes in the
novel ATP-producing pathway are induced following Myc
induction, and all, but two (Psat1 and Psph), return to their
control levels upon Myc downregulation-induced tumor regression
(Fig. 5). Thus, activation of the novel ATP-producing pathway is
evident upon Myc-induced tumorigenesis.
Discussion
The existence of an alternative glycolysis pathway with net zero
ATP production in rapidly proliferating cells [12,13] challenges
the general notion that the production of ATP is a major function
of glycolysis. Instead, an alternative hypothesis suggests that the
increased rate of glycolysis in rapidly proliferating cells is present
to support the increased demand for precursor metabolites by
anabolic processes involved in cell growth and proliferation [33].
However, based on a partial- or full genome-scale reconstruction
of human cell metabolism [17,22] containing the standard
glycolysis pathway, we [15,16] and others [14] have shown that
the anabolic requirements can be satisfied without the need for a
dramatic upregulation of glycolysis and the excretion of lactate.
We have recapitulated this result here, now using the alternative
glycolysis pathway with net zero ATP production, providing in
silico evidence that the demand for precursor metabolites can be
satisfied without upregulation of the alternative glycolysis pathway
(Fig. 2).
We have shown previously that molecular crowding is a major
determinant of the metabolic changes observed in highly
proliferating mammalian- [15,16] and prokaryotic cells [18,34]
and in quiescent cells with high energy demands [15]. In essence,
the high density of macromolecules in the intracellular millieu
results in a ‘competition’ among mitochondria, ribosomes,
metabolic enzymes and structural protein for the available
intracellular space. At low metabolic rates this constraint is less
pronounced, and therefore the density of the required organelles
and macromolecules can increase to accommodate the increasing
metabolic rate. However, just as a finite number of people can be
placed in a room, only a finite amount of mitochondria can be
present in the cell, resulting in an upper bound for OxPhos
capacity. To satisfy its energetic needs beyond this maximum
OxPhos capacity the cell need to switch to other pathways that are
less costly in terms of the required cell volume fraction to allocate
the corresponding enzymes, such as the classic glycolysis pathway.
However, this hypothesis has been challenged by the observation
that highly proliferating cells utilize an alternative glycolysis
pathway with net zero ATP production [12]. To resolve this
contradiction we have improved our genome-scale metabolic
model of a human cell to be able to investigate the consequences of
a net zero ATP production glycolysis.
The results of our in silico analyses yield several surprising
observations. The glycolysis flux is upregulated in highly
proliferating cells and it is routed from 3-phosphoglycerate toward
serine biosynthesis. This prediction is supported by experimental
observations in both cancer- and highly proliferating normal cells.
Rapidly proliferating normal cells (including embryonic cells and
adult stem cells) and cancer cells express the M2 isoenzyme of
pyruvate kinase (PKM2) [13]. The PKM2 isoform can be present
either as a tetramer with high PK catalytic activity or as a dimmer
with low catalytic activity, in the latter case greatly reducing the
rate over the last steps of standard glycolysis [12,13,35]. The
upregulation of serine and glycine biosynthesis were observed both
in various tumor types [25,26,27,28,29] and mitogen-activated
Figure 3. Selected reactions contributing to ATP generation at
different proliferation rates. Contribution of ATP synthase, phos-
phoglycerate kinase (PGK), pyruvate kinase (PK) and formate-tetrahy-
drofolate ligase (FTHFL) to ATP generation in cells at low (0.03/day, left)
and high (2.52/day, right) proliferation rates. The ATP consumed for cell
maintenance (black) is shown as a reference. a) cells using the
alternative glycolysis pathway with net zero ATP production. b) cells
using the standard glycolysis.
doi:10.1371/journal.pone.0025881.g003
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normal lymphocytes [36], and serum stimulation of Rat1A
fibroblast proliferation resulted in an increased 13C-labeled glycine
derived from 3-phosphoglycerate, in a myc dependent manner
[37]. Also, when found upregulated, the serine biosynthesis
pathway’s enzymes are individually essential both for the growth
of a subset of breast cancer- and melanoma cell lines [27,28,29]
and for tumorigenesis in 3-dimensional in vitro- [29] and in vivo
breast cancer models [28]. More importantly, we provided
evidence that the expression of genes in this pathway correlates
with Myc overexpression in a Myc-driven murine tumor model
(Fig. 5). These observations support the activity of the novel ATP-
producing pathway in a subset of tumors and, in particular, in Myc
driven tumors.
Our in silico approach allow us to investigate the fate of the high
rate of the serine biosynthesis pathway. We discover that its final
endpoint is a novel pathway for ATP generation, starting from the
biosynthesis of serine and involving reactions in the one-carbon
metabolism pathway and the serine cleavage system (Fig. 4). The
reaction responsible for the net ATP generation is catalyzed by
formate-tetrahydrofolate ligase (EC 6.3.4.3), working in the ATP
production direction. This pathway has a yield of 2 mole of ATP
per mole of 3-phosphoglycerate, or 4 moles of ATP per mole of
glucose. Taken together our in silico evidence indicates that, even
in the context of an alternative glycolysis pathway with net zero
ATP production, glycolysis is upregulated to satisfy the high
energy demand of highly proliferating cells, during conditions
where molecular crowding imposes a bound or a reduction in the
mitochondrial density.
The novel pathway doubles the ATP yield from 2 to 4 mole of
ATP per mole of glucose (Table 1). The novel pathway requires,
Figure 4. Novel ATP producing pathway. The fate of the high glycolysis flux in cells utilizing the alternative glycolysis [7]. The squared panels
show the rate of the indicated reaction (vertical axis, in units of mM/min=mmol/min/L) as a function of the proliferation rate (horizontal axis, in units
of 1/day). The gray shadow background contains reactions taking place in the mitochondria. Metabolite and enzyme abbreviations: 3-
phosphoglycerate (3 pg), phosphoglycerate dehydrogenase (PHGDH), 3-phosphohydroxypyruvate (3php), L-glutamate (glu-L), phosphoserine
transaminase (PSAT), a-ketoglutarate (aKg), L- phosphoserine (pser-L), phosphoserine phosphatase (PSPH), L-serine (ser-L), tetrahydrofolate (thf),
serine hydroxymethyltransferase (SHMT), glycine (gly), 5,10-methylene tetrahydrofolate (mlthf), methylenetetrahydrofolate dehydrogenase (MTHFD),
5,10-methenyl-tetrahydrofolate (methf), methenyltetrahydrofolate cyclohydrolase (MTHFC), 10-formyltetrahydrofolate (10thf), formate (for), formate-
tetrahydrofolate ligase (FTHFL), S-aminomethyldihydrolipoylprotein (alpro), dyhydrolipolprotein (dhlpro), lipoylprotein (lpro), S-aminomethyldihy-
drolipoamide (alpam), dihydrolipoamide (dhlam), and lipoamide (lpam). glycine-cleavage complex with lipoylprotein (GCCam, GCCbim and GCCcm)
and glycine-cleavage complex with lipoamide (GCC2am, GCC2bim and GCC2cm).
doi:10.1371/journal.pone.0025881.g004
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however, the balance of several co-factors and thus it is coupled to
several other reactions. Yet, it remains to be elucidated what the
potential evolutionary advantage of having two alternative
glycolysis pathways is (i.e., the net zero ATP and the standard
pathways). As we show here, the novel pathway can generate two
times more ATP, thus an energetic reason is probably likely. In
contrast, the novel pathway involves 17 reactions, 7 more than the
standard glycolysis, potentially contributing more to molecular
crowding. Taken together with OxPhos, we obtain a hierarchy in
terms of ATP yield: OxPhos..net-zero-ATP-glycolysis.stan-
dard-glycolysis, and the same hierarchy in terms of molecular
crowding. Therefore, these pathways provide the cell with
different alternatives to cope with competing efficiency principles,
ATP yield per mole of substrate or ATP yield per occupied volume
fraction. Concomittantly, other factors, such as the cellular lactate
and alanine production also has several potential advantages on
the population level that may enhance the invasiveness of tumor
cells. Also, tumor cells frequently encounter fluctuating hypoxia
levels within growing tumors [38] requiring a capability to rapidly
deploy alternative metabolic strategies [39]. In any event, our
model identifies several metabolic changes that can be subject to
further theoretical and experimental investigations and delineates
potential enzyme targets for treatment modalities attempting to
interfere with cancer metabolism.
Materials and Methods
Metabolic network reconstruction
The reactions annotated in H. sapiens metabolic reconstruction 1
were downloaded from the BiGG database [22]. They are listed in
Table S1, together with all auxiliary reactions.
Crowding coefficients
Dividing the mitochondrium specific volume (3.15 mL/g in
mammalian liver [40] and 2.6 mL/g in muscle [41]) by the rate of
ATP production per mitochondrial mass (0.1–1.0 mmol ATP/
min/g [42,43,44]) we obtain aM values between 0.0026 to
Figure 5. Transcriptional upregulation of the novel pathway in a Myc-induced tumor. Gene expression profiles of genes in the novel ATP
producing pathway at different stages of a doxycycline-inducible Myc driven liver cancer [32]. Controls are samples from adjacent normal tissue,
‘‘Pre.Tumor’’ are tumor samples taken 4–5 weeks after Myc induction, ‘‘Tumor’’ are tumor samples taken 8–10 weeks after Myc induction and
‘‘Regression’’ are tumor samples taken 3 days after removal of Myc induction. Color intensity is proportional to change in expression relative to the
average across all samples, with red color indicating increased- and green color indicating decreased gene expression. Repeated gene names
represent different microarray probes for the same gene.
doi:10.1371/journal.pone.0025881.g005
Table 1. Overall reaction.
a) Glycolysis
Glucose+2 ADP+2 PhosphateR2 Lactate+2ATP+2 H2O+2 H+
b) Novel ATP generating Pathway
Glucose+2 L-glutamate+6 NAD++4 NADP+6 H2O+4 ADP+4 PhosphateR
2 NH4+2 a-ketoglutarate+6 NADH+4 NADPH+4 ATP+14 H++2 CO2
doi:10.1371/journal.pone.0025881.t001
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0.032 min/mM. Except when specified, we use the median
0.017 min/mM. Dividing the ribosome molar volume (vR=
4,000 nm366.02 1023/mol= 2.4 L/mmol) by the rate of protein
synthesis per ribosome (0.67 proteins/min [45]) we obtain
aR=3.6 min/mM. The enzyme crowding coefficients were esti-
mated as ai= vE/ki. Multiplying the median molecular weight of
human enzymes (98,750 g/mol, BRENDA [19], Table S2) by the
enzymes specific volume (approximated by the specific volume of
spherical proteins, 0.79 mL/g [46]) we obtain an estimated
enzymes molar volume of vE=0.078 L/mmol.
Sensitivity analysis
The turnover numbers of human enzymes k have significant
variations from 1 to 100 sec21 and the distribution of log10(k) is
approximately uniform in this range (BRENDA, [19], Table S2).
Based on this data we sampled the log10(keff) values from a uniform
distribution in the range between log10(1) to log10(100). At each
proliferation rate we run 100 simulations. On each simulation, for
each reaction, a value of keff,i is extracted from the distribution
described above. With this set of keff,i parameters we then solve the
optimization problem (1)–(5) and obtain estimates for the reaction
rates. Based on the 100 simulations we finally estimate the median
and 90% confident intervals for the rate of each reaction. This
data is reported in Figures 2–4 for selected reactions.
Macromolecular composition
Proteins were divided into three pools: ribosomal-, components of
metabolic enzyme complexes-, and non-metabolic proteins. Each
ribosome contributes to nPR=82 proteins/ribosome (49 in the 60S
and 33 in the 40S subunits [47]). The ribosomal protein
concentration was computed as PR= nPRwR/vR. Each enzyme
contributes with nPE=2.4 proteins in average, estimated as median
enzyme molecular weight (98,750 g/mol, reported above) divided by
the median molecular weight of a human protein (40,835 g/mol).
The median molecular weight of a human protein was estimated
from the median protein length (355 amino acids [48]) and the typical
amino acid composition [49]. The enzyme related protein concen-
tration was computed as PE=SinPEfi/ki. The concentration of non-
metabolic proteins was estimated as 85% (10% metabolic enzymes
and 5% ribosomal protein [48]) of the reported total protein content
per cell dry weight (0.018 mmol/g DW [49]), i.e. 0.015 mmol/g
DW.The lipids, DNA and RNA composition were estimated by their
relative abundance in a generic mammalian cell [49]. The
abundance per cell dry weight were converted to concentrations
after dividing by the typical cell specific volume 4.3 mL/g [50]. This
resulted in a concentration of non-metabolic protein of
P0=3.59 mM. The maximum macromolecular density of human
cells in the absence of osmotic stress is around wmax=40% [51].
Maintenance parameters
The ATP production rate necessary for cell maintenance is
1.55 mmol ATP/g DW/h [49]. The basal protein degradation
rate was estimated as kD(P0+PE+PR), where kD=0.01/h [52].
Simulations
The optimization problem in equations (1)–(5) was solved in
Matlab, using the linear programming function linprog. All
reversible reactions were represented by an irreversible reaction
on each direction with their own effective turnover number keff,i.
Most flux bounds were set to vi,min=0 and vi,max=‘, unless
specified otherwise (Table S1).
Kinetic model
The kinetic model is described in the Information S1.
Microarray data analysis
The Gene expression dataset reported in [32] was downloaded
from the Gene Expression Omnibus (GEO:GSE28198)). RMA
normalized signals were calculated andmean-centered across samples.
Supporting Information
Figure S1 Selected reactions contributing to ATP gen-
eration at different proliferation rates. Contribution of
ATP synthase, phosphoglycerate kinase (PGK), pyruvate kinase
(PK) and formate-tetrahydrofolate ligase (FTHFL) to ATP
generation in cells at low (0.03/day, left) and high (2.52/day,
right) proliferation rates, in cells using the alternative glycolysis
pathway with net zero ATP production, after removing the
molecular crowding constraint. The ATP consumed for cell
maintenance (black) is shown as a reference.
(TIF)
Table S1 List of biochemical reactions and auxiliary reactions in
the large-scale metabolic model.
(XLS)
Table S2 List of molecular weights and turnover numbers for
selected human metabolic enzymes.
(XLS)
Information S1 Kinetic model of the one carbon metab-
olism cycle.
(PDF)
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